CONCLUSION
In summary, CD15+LOX-1+ PMN-MDSC proportion increases in PB of NSCLC patients, and combined detection of PMN-MDSCs and traditional tumor markers can promote the diagnostic sensitivity and specificity for NSCLC. Moreover, CD15+LOX-1+ PMN-MDSCs are associated with NSCLC prognosis and recurrence after surgery.